The Cuban Center for Genetics Engineering and Biotechnology (CIGB) will be 20 years old on July 1, with seven great achievements.
Over 500 scientists work there, and many of them are promising youths that lose track of the time, immerse in research, without regret. They enjoy it instead.
It is not surprising that Cuban biotechnology had become a milestone that not only favors the national population, but also that of all over the world.
The scientists of the Island have developed efficient biomedical, agricultural, aquatic, and environment-protecting products, and they are working on others devoted to social benefit.
The country counts on 18 products obtained in the CIGB, which are currently used in the Cuban health system, as four vaccines, and important pharmaceutical products as interferon and recombinant streptoquinase, against hemorrhagic dengue and cardiac arrests, respectively.
The CIGB has already patented and registered many of its achievements, and transferred technology to several countries.
This “is an institution with dynamic development, which has allowed it to reach a high level in research, development, production, and trade of biological products,” General Director, Luis Herrera Martinez said.
ICGB Vice director Carlos Borroto called it recently a milestone in international science, because the technology used to obtain that result was mastered in all stages.
The list of impacts of Cuban biotechnology is long in just 20 years, and will be longer due to the joint work of the scientific institutions, which are at the service of society.
cuban government, cuban health, cuban medicine